Gene · 5754
Papers1,606
Newest first. Swiss-Prot's references are curated; PubTator's text mining finds papers that name the gene, not always ones about it.
321 to 340 of 1,606
Download this page as JSON| Title | Journal | Year | PMID | Found by | Source |
|---|---|---|---|---|---|
| Facile, rapid and efficient isolation of circulating tumor cells using aptamer-targeted magnetic nanoparticles integrated with a microfluidic device. | RSC Adv | 2022 | 36425208 | PubTator, text mining | PubMed |
| Strategies for developing long-lasting therapeutic nucleic acid aptamer targeting circulating protein: The present and the future. | Front Cell Dev Biol | 2022 | 36393853 | PubTator, text mining | PubMed |
| Plasma proteomic characterization of the development of acute kidney injury in early sepsis patients. | Sci Rep | 2022 | 36385130 | PubTator, text mining | PubMed |
| Antibody Drug Conjugates in Lung Cancer. | Cancer J | 2022 | 36383905 | PubTator, text mining | PubMed |
| Vaccination History, Body Mass Index, Age, and Baseline Gene Expression Predict Influenza Vaccination Outcomes. | Viruses | 2022 | 36366544 | PubTator, text mining | PubMed |
| Vitamin D in Cancer Prevention: Gaps in Current Knowledge and Room for Hope. | Nutrients | 2022 | 36364774 | PubTator, text mining | PubMed |
| Diagnostic and Therapeutic Implications of Long Non-Coding RNAs in Leukemia. | Life (Basel) | 2022 | 36362925 | PubTator, text mining | PubMed |
| The Landscape of Nucleic-Acid-Based Aptamers for Treatment of Hematologic Malignancies: Challenges and Future Directions. | Bioengineering (Basel) | 2022 | 36354547 | PubTator, text mining | PubMed |
| High Electrochemiluminescence from Ru(bpy)3 2+ Embedded Metal-Organic Frameworks to Visualize Single Molecule Movement at the Cellular Membrane. | Adv Sci (Weinh) | 2022 | 36328787 | PubTator, text mining | PubMed |
| A stimulus-responsive hexahedron DNA framework facilitates targeted and direct delivery of native anticancer proteins into cancer cells. | Chem Sci | 2022 | 36320481 | PubTator, text mining | PubMed |
| Advances in regenerative medicine applications of tetrahedral framework nucleic acid-based nanomaterials: an expert consensus recommendation. | Int J Oral Sci | 2022 | 36316311 | PubTator, text mining | PubMed |
| Direct Identification of Proteolytic Cleavages on Living Cells Using a Glycan-Tethered Peptide Ligase. | ACS Cent Sci | 2022 | 36313159 | PubTator, text mining | PubMed |
| Liquid biopsy in gastric cancer: predictive and prognostic biomarkers. | Cell Death Dis | 2022 | 36302755 | PubTator, text mining | PubMed |
| Mining of transcriptome identifies CD109 and LRP12 as possible biomarkers and deregulation mechanism of T cell receptor pathway in Acute Myeloid Leukemia. | Heliyon | 2022 | 36299526 | PubTator, text mining | PubMed |
| Bioimaging Nucleic-Acid Aptamers with Different Specificities in Human Glioblastoma Tissues Highlights Tumoral Heterogeneity. | Pharmaceutics | 2022 | 36297416 | PubTator, text mining | PubMed |
| Anti-PTK7 Monoclonal Antibodies Exhibit Anti-Tumor Activity at the Cellular Level and in Mouse Xenograft Models of Esophageal Squamous Cell Carcinoma. | Int J Mol Sci | 2022 | 36293051 | PubTator, text mining | PubMed |
| AgeMTPT, a Catalyst for Peptide N-Terminal Modification. | ACS Synth Biol | 2022 | 36279362 | PubTator, text mining | PubMed |
| A CRISPR/Cas12a-responsive dual-aptamer DNA network for specific capture and controllable release of circulating tumor cells. | Chem Sci | 2022 | 36277631 | PubTator, text mining | PubMed |
| Tumor buster - where will the CAR-T cell therapy 'missile' go? | Mol Cancer | 2022 | 36261831 | PubTator, text mining | PubMed |
| Outward Movement of Targeting Ligands from a Built-In Reserve Pool in Nuclease-Resistant 3D Hierarchical DNA Nanocluster for in Vivo High-Precision Cancer Therapy. | Adv Sci (Weinh) | 2022 | 36253152 | PubTator, text mining | PubMed |
gene-search-2026-11-11-0.2.0
Sources 12
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- EMBL-EBI's patent proteinsNo added restrictions. Attribution expected
- GenBank's patent filesNo restrictions from NCBI. Submitters may hold rights
- HGNCCC0
- NCBI GenePublic domain (US government)
- NIH's project files and grant-paper linksPublic domain
- Open TargetsCC0 1.0
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- EMBL-EBI's patent proteinsEMBL-EBI's patent protein files from the EPO, JPO, KIPO and USPTO. EMBL-EBI: "EMBL-EBI itself places no additional restrictions on the use or redistribution of the data available via its Data Resources and Tools other than those provided by the original data owners" and "EMBL-EBI expects attribution (e.g. in publications, services or products) for the use of any of its Data Resources and Tools." Read on 11 Nov 2026 at https://www.ebi.ac.uk/about/terms-of-use
- GenBank's patent filesGenBank's patent files. NCBI: "NCBI places no restrictions on the use or distribution of the GenBank data. However, some submitters may claim patent, copyright, or other intellectual property rights in all or a portion of the data they have submitted." Read on 11 Nov 2026 at https://www.ncbi.nlm.nih.gov/genbank/about/
- HGNCCC0: https://www.genenames.org/about/license/
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH's project files and grant-paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/genes/v1/5754/papers?page=17